Program
Certification by Professional Orders
All the participants, whether presenters or auditors, can benefit of certification by professional orders.
–QUEBEC ORDER OF PHARMACISTS: This continuing education activity program has been accredited by the Ordre des Pharmaciens du Québec, which will grant 16 CEU to pharmacists who have followed the entire program.
–QUEBEC BAR ASSOCIATION: This 16 hour course is offered by an accredited provider of mandatory continuing professional development.
–QUEBEC COLLEGE OF PHYSICIANS: The Continuing Professional Development (CPD) Office of the Faculty of Medicine of the University of Montreal is fully accredited by the Association of Faculties of Medicine of Canada (AFMC) and from the Quebec College of Physicians. For general practitioner/family medicine physicians, the Continuing Professional Development (CPD) Office recognizes a maximum of 16 credit hours of Category 1 for the entire program. For specialists, the Vice Dean recognizes 1 credit per hour of participation (Section 1), for a maximum of 16 credits for the entire program as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. For all other participating professionals, this program provides a certificate of participation of 16 hours. Participants must claim the number of hours according to their participation.
In every case, all participants who want to receive a participation certificate must register their attendance at the registration table (Foyer Grand Salon Opera, level four, Hyatt Hotel).
Furthermore, they have to:
Members of the Ordre des pharmaciens du Québec :
Register their attendance at the beginning of each day at the registration table. They must fill out and sign a form. They must hand in the completed form at the end of the conference.
Members of Quebec College of Physicians
Register their attendance at the beginning of each day at the registration table and sign a register. Prepare a check of 8,05$, required by CPASS to open an individual account. The check must be made to "University of Montreal".
Members of the Quebec Bar (or other bars)
Register their attendance at the beginning of each day and after lunch time on both days at the registration table and sign a register
FOR ALL THE PRESENTERS (whether oral or posters): Mandatory Disclosure of Potential Conflict of Interests
Press release on Aug. 13th 2015 To comply with applicable regulations, all the presenters have to:
1-Fill out and sign a potential conflict of interests form and send it back as soon as possible to this email address: elisabeth.lanctot@hotmail.com
POTENTIAL CONFLICT OF INTERESTS DISCLOSURE FORM
2- If you are in a conflict of interests, you must declare that conflict at the beginning of your presentation and you must include a slide explaining the nature of that conflict in your powerpoint presentation or include a note on your poster.
Program
DAY 2 – THURSDAY AUGUST 20TH 2015
Starting at 7.00 am
- Registration —Foyer Grand Salon Opera, level 4
- Installation of posters — Foyer Grand Salon Opera, level 4
NB: Every symposium and oral communications of the Conference will be held at the Grand salon Opera (level 4).
7.45 am Welcome: Chair of the Conference and Director of the IIAPC, Canadian Division, Violaine Lemay (UdeM)
8.00-8.45 am Opening: Chief Scientist of Quebec, Dr Rémi Quirion
—«Personalized Medicine or Precision Medicine: Challenges and a Role for the Chief Scientist »
(in french, with simultaneous translation)
8.45 - 10.15 am Symposium of Pharmacological/ Pharmaceutical Sciences Theme
Roundtable Themes: • Personalized Pharmacotherapy Issues; • Clinical Research Implications; • Pharmacists’ Importance in the Implementation of Change; • Economic Issues and Personalized Medicine
Dr Candan Hizel, PhD; Doctor of Science in Molecular Biology-Genetics; Consultant-expert in Genomics for Health & Biotechnology; Prof, Dokuz Eylül University (İzmir, Türkiye); Research Director, Personalized Medicine and Pharmacogenomics/genetics Research Centre-BIFAGEM, (Izmir, Türkiye)
— « Pharmacogenomics Knowledge Databases for Individual Approach by Help Decision Making System in Prediction of Patient Drug Metabolism Efficacy »
Dr Simon DeDenus, Professor at the Faculty of Pharmacy, Beaulieu-Saucier Chair in Pharmacogenomics (UofM)
—« PGx, heart failure and individualization of response to treatments»
Dr Jean Lachaîne, Member, Scientific Committee Quebec’s Institut national d'excellence en santé et en services sociaux (INESSS) as the expert in pharmacoeconomics, Professor at the Faculty of pharmacy (UofM)
- « Economic challenges of personalized medicine »
Dr Chantal Pharand, Former Dean of the Faculty of Pharmacy (UofM) — Moderator
10.15-10.30 am Foyer Grand Salon Opera (level 4)
Coffee break and snacks + Posters visit
NB: It is an informal visit combined with the break, with or without presentors (at their discretion). The day after, 30 minutes will be exclusively dedicated to the posters and their presentors —see below, Day 3 - Friday August 21st 10.00-10.30 am : "Featured posters".
10.30-12.20 am Presentations/ Pharma Sciences
Session Chair : Dr Marie Lordkipanidzé (UofM)
10.30-10.50 am Opening of the Theme : Dr Marie Lordkipanidzé, Pharmacist and Clinical Pharmacologist, Professor at the Faculty of Pharmacy (UofM) and Researcher at the Montreal Heart Institute
— « An aspirin a day may not always keep the doctor away »
10.50-11.05 am Simon Lessard, Community Pharmacist, Innovation Award from the Ordre des pharmaciens du Québec in 2011
— « The pharmacy of tomorrow… the time is now. »
11.05-11.20 am Dr Lea Prevel Katsanis Professor in the Department of Marketing at (Concordia University)
— «The Role of Pharmaceutical Marketing in the Adoption of Personalized Medicine by Consumers »
11.20-11.35 am Sandra Korol, Ph.D. Candidate in Pharmaceutical Science, Faculty of Pharmacy (UofM)
—« Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients »
11.35-11.50 am Dr Veljko Dubljević, Banting Postdoctoral Fellow, Neuroethics research unit (IRCM and McGill University), Associate Member of the International Centre for Ethics in the Sciences and Humanities (University of Tübingen)
— « Enhancing with Modafinil: Benefiting or Harming Society? »
11.50 am - 12.30 pm Research Panel, Dr Krajinovic’s laboratory/CHU Ste-Justine/Centre de cancérologie Charles-Bruneau
Sanja Glisovic Joksimovic, M.Sc. Candidate in Pharmacogenomics, Faculty of Medicine (UdeM), department of Pharmacology.
— « The relationship between genetic polymorphisms determining the white blood cell / neutrophil count and toxicity of chemotherapy with children with acute lymphoblastic leukemia (ALL) »
Mohammed Aziz Rezgui, Researcher, graduate studies, Hematology-Oncology Division, Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center
— «Genetic determinants of busulfan clearance and clinical outcomes in pediatric patients undergoing hematopoietic stem cell transplantation»
Pamela Mehanna, M.Sc. Candidate in Bioinformatics
— « Characterization of the microDNome and its impact on the differential sensitivity to cancer treatments»
________________________________________________________________________________________________________________________________
12.20-1.30 pm
Lunch on site
Please note that the excellent chef Simon Renaud will be pleased to accommodate participants who have food restrictions (allergies, food intolerances, vegeterianism, etc.), but it is necessary to notify the organisation before, ideally before the start of the conference.
________________________________________________________________________________________________________________________________
1.30-3.00 pm Symposium of Legal Sciences and Ethics Theme
Roundtable Themes: •State Governance and Pharmaceutical powers; • Genetic predictor and discrimination risk; • Human genome technologies and manipulation of the human living; •Administration of personalized care and collaborative approaches
Bartha Knoppers, Canada Research Chair in Law and Medicine, Professor, and Director of the Centre of Genomics and Policy, Faculty of Medicine, Human Genetics (McGill University)
—«From “Big Data” to personalized medicine?»
Trudo Lemmens, Scholl Chair in Health Law and Policy, Professor at the Faculty of Law with cross appointments at the Faculty of Public Health, and at the Joint Centre for Bioethics (University of Toronto)
— « Ethical, Legal and Policy Challenges of Niche Markets and Pharmacogenomic Drug Development »
Me Olga Farman, Partner at Norton Rose Fulbright, Lawyer specialized in life sciences and in charge of files related to promoting and financing of research in hospitals.
— « Title : Issues and business challenges »
Benoit Moore, Former Dean of the Faculty of Law, Jean-Louis Baudouin Chair (UofM) — Moderator
3.00-3.10 pm Foyer Grand Salon Opera (level 4)
Coffee break and snacks + posters visit
3.10-5.20 pm Presentations on Legal Sciences and Ethics Theme
Session chairs: Professor Mélanie Bourassa-Forcier and Professor Anne-Marie Savard
3.10-3.35 pm Opening of the Theme by the ambassadors of the Health Law Program of the Université Sherbrooke, official partner of the conference: Mélanie Bourassa-Forcier and Anne-Marie Savard, Professors at the Faculty of Law (UofS)
— «Personalized Medicine: Economic, Legal and Ethical Issues».
3.35-3.50 pm Pierre Trudel, Professor at the Centre de recherche en droit public (CRDP) at the Faculty of Law (UofM)
— « Analysis of the legal challenges and risks of e-health networks »
3.50pm - 4.05pm Me Nicole Beaudry, General Secretary at Commission de l’éthique en science et en technologie
— « “Personalized” health care: prudence and guidance »
4.05pm - 4.20 pm Julie Cousineau, Professor, Faculty of Medicine (UofM)
— « Le Bureau de l’éthique clinique de la Faculté de médecine de l’Université de Montréal : Un regard original sur le concept de médecine personnalisée »
4.20-5.00 pm Research panel, Center of Genomics and Policy (UMcGill)
Me Ida Ngueng Feze, Member of the New York Bar, Academic Associate at the Centre of Genomics and Policy (McGill University)
— « Genetic Discrimination and Insurance: Some considerations »
Me Shahad Salman, Member of the Quebec Bar, Academic Associate at the Centre of Genomics and Policy (McGill University)
— « Medical liability and interdisciplinarity in individualized cancer care: the case of the use of the Oncotype DX »
Me Adrian Thorogood, Member of the Ontario Bar, Academic Associate at the Centre of Genomics and Policy (McGill University), M.A. Candidate in Bioethics (UofM)
— « A right to access individual genomic data in research? »
5.00-5.30 pm Closing conference of the first day
Yann Joly, Research Director of the Centre of Genomics and Policy, Professor in the Department of Human Genetics and the Bioethics Unit, Faculty of Medicine (UMcGill)
—«Cancer personalised medicine: potential and challenges »
________________________________________________________________________________________________________________________________
17h50 Grand Salon Opéra
Fifth General Assembly of International and Interdisciplinary Association of Pharmaceutical Life Cycle (IIAPC)
Please note that the registration to the conference includes a membership to the IIAPC organisation. All congressists are welcome to attend the general assembly. For those who are interested to become a member of the advisory council, we kindly ask you to submit your application on or before August 13th.
Related material:
OJ ASS.GEN.-AIICM-20aout 2015_congresMTL
P-V ASS.GEN.-AIICM-26fev2014-versionFinale
Appel candidatures au CA de l'AIICM au congres Mtl.aout 2015
________________________________________________________________________________________________________________________________
DAY 3: FRIDAY AUGUST 21ST 2015
Starting at 7.00 am:
-Registration, foyer Opera (level 4)
-Installation of posters, foyer Opera (level 4)
7.45 am Welcome
8.00-8.15 am Opening
Dr Guy Breton, University of Montreal's Rector
(in french, with simultaneous translation)
8.15-9.45 am Symposium of Biomedical Sciences Theme
Roundtable Themes: • Issues of a “4 P” medicine ; • Practical conditions of a personalized approach ; • Researchers and practioners’ role regarding personalized care ; •New faces of the geneticist in the medical world
Dr Eddy Karnieli, Professor of Medicine, President of Israel Endocrine Society, Dr. Joel Hamburger Chair of Internal Medicine and Endocrinology, Emeritus Director of Inst. Endocrinology, Diabetes & Metabolism (Rambam Medical Center), Director of Galil Center for Telemedicine, Medical Informatics and Personalized Medicine, RB Rappaport Faculty of Medicine - Technion (Haifa, Israel)
— «Barriers in the implementation of personalized medicine into clinical practice »
Dr Jacques Simard, Canada Research Chair in Oncogenetics, Professor in Molecular Medicine (ULaval), Deputy Director of Basic Research at CHU de Québec
— « Towards a comprehensive understanding of the inherited genetic susceptibility to breast cancer for personalized risk stratification. »
Dr Bruce McManus, Co-Director of the Institute for Heart + Lung Health, CEO of the Centre of Excellence for Prevention of Organ Failure (PROOF Centre), Director of the James Hogg Research Center, Professor in the Department of Pathology and Laboratory Medicine (UBC)
— «High Tides for Personalized Medicine: A Perspective from the West Coast»
Dr. Guy Breton, Doctor, Radiologist and Rector of the University of Montreal —Moderator
9.45-10.00 am Coffee break and snacks
10.00-10.30 am Featured posters
NB: The presenters are asked to stand close to their posters in order to answer participants’ questions.
By alphabetical order:
Duygu Abbasoglu, Ph.D Candidate in Pharmaceutical Sciences, Anadolu University (Turkey).
— «Relevance of UDP-glucuronosyltransferase polymorphisms in Turkish Colon Cancer patients treated with Irinotecan» (Pharma Theme)
Dr Patrick Bergeron, Professor, Biology Department, Bishop's University.
— « The Continuum of Care to Improve Patient Health: a Quantitative Approach using Electronical Medical Record» (Biomedical Theme)
Dr Gulay Büyükköglu, Professor, Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University (Turkey).
— « Development of Lipidic Carrier Systems with anti-HER2 Antibody for Targeting Therapy» (Pharma Theme)
François Harvey, Informatician, CRCHUM/UofM
—«Distinct Genetic Architecture of Renal Impairement Components in Type 2 Diabetes within Caucasian Populations of Celtic and Slavic Origin» (Biomedicine Theme and Interdisciplinary Theme)
Martin Hétu, Research Professional, Centre of Genomics and Policy (McGill University)
— «La médecine génomique en santé internationale : Le rôle des projets internationaux de science ouverte en génomique» (Law and Ethics Theme)
Dr Alena Krajcoviechova, Cardiology Fellow and Ph.D. Candidate, Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital (Prague)
— «Mean arterial pressure and visceral adiposity index amplify the association of serum uric acid with albumin/creatinine ratio in pre-metabolic syndrome» (Biomedicine Theme)
Kevin Lota, Master's Candidate in Medical Ethics and Bioethics, European Center for the Study and Teaching of Ethics (ECSTE), Université de Strasbourg, France.
—«Ethical issues in predictive medicine» (Law and Ethics Theme )
Joanie Mercier, Physiotherapist, Ph.D Candidate in Rehabilitation Sciences (UofM), member of the Réseau québécois de recherche sur le vieillissement, Ordre de la physiothérapie du Québec/ Centre de recherche de l’Institut universitaire de gériatrie de Montréal
—«Pelvic floor muscles training to improve vaginal atrophy signs and symptoms: a case study » (Biomedicine Theme)
Vincent Picher-Martel, Ph.D Candidate in Neurobiology, Centre de recherche de l’institut universitaire en santé mentale de Québec (CRIUSMQ)/ Université Laval
—«Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells» (Biomedicine Theme)
Paul Simon, Ph.D Candidate in Experimental Medicine (McGill University)
—«Genetic Determinants of Unmet Needs in the Treatment of Kidney Disease in Type-2 Diabetes» (Biomedicine Theme)
10.30 am- 12.20 pm Presentations of Biomedical Sciences Theme
Session Chair: Dr Yves Tremblay (ULaval)
10.30-10.45 am Dr José Morais, Associate Director of the FRQS - Network for Research in Aging, Associate Professor, Department of MedicineDirector, Division of Geriatric Medicine School of Dietetics and Human Nutrition, Department of Experimental Medicine MUHC- Royal Victoria Hospital
—« Healthy aging: a rocky road from population data to personalized medicine »
10.45-11.00 am Dr Johanne Tremblay, Leader of the cardiometabolic theme and Chief of Laboratory of Cell Biology of Hypertension at CHUM Research Center, Professor of Medicine (UofM)
— « OPTITHERA: A Public-Private Partnerships for Personalized Medicine in Quebec with a Focus on diabetes and its complications »
11.00-11.15 am Dr Corentin Babakissa, M.D., M.Sc., Pediatric Gastroenterologist, Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke
— « Modulation of inflammatory response in human immature intestine by EGF »
11.15-11.40 am Dr Jacques Tremblay, Professor, Departement of Molecular Medicine, Université Laval, Regular Researcher at CHU de Québec Research Center, Neuroscience principal area of research
— « Correction of the Amyloid Precursor Gene with the CRISPR/Cas9 system »
— « Development of a gene therapy treatment for Friedreich ataxia »
11.45 am-12.00 pm Dr Catherine Laprise, Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy, Professor, Fundamental Sciences Department, Université du Québec à Chicoutimi
— « Définir la nature biologique de l'asthme et de l'allergie pour contribuer à une médecine personnalisée »
12.00-12.15 pm Dr Zaki El Haffaf, Medical Geneticist at Genetic Medicine Department, CHUM
— « Réalités actuelles de la pratique de la génétique médicale. Succès et incertitudes »
12.15-12.30 pm Dr Mathieu Noury, Postdoctoral Fellow at the School of Sociological and Anthropological Studies at the University of Ottawa
— «Personalized Medicine and Nanomedicine: Understanding the Issues of the Personalization of Healthcare in the Era of Molecular Technologies »
_________________________________________________________________________________________________________________________________
12.30-1.30 pm
Lunch, on site
__________________________________________________________________________________________________________________________________
1.30-1.50 pm Opening of Human Sciences/Interdisciplinarity Theme
The Honorable James Cowan, canadian senator
— «Discrimination Protected: an Insider's View on Politics, Partisanship and Personalized Medicine »
1.50-3.05 pm Presentations of Human Sciences/Interdisciplinarity Theme
Session Chair : Prof. Chantal Bouffard (Université de Sherbrooke)
1.50-2.05 pm Chantal Bouffard, Professor, Service of Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke and Professor, Ophtamology and Otoralyngology – Cervicofacial surgery at the Faculty of Medicine of Université Laval
— « 4P" medicine as a "total social fact »
2.05-2.20 pm Dr Yves Tremblay, Senior scientist at CHU of Québec and Professor in the Department of Obstetrics, Gynecology & Reproduction of Université Laval
— « Inescapable interdisciplinarity to face with complex medical questions: the example of the consequences of a premature birth and the sex of the infant on his perspective of health. Université Laval et CHU de Québec, CRCHUL »
2.20-2.35 pm Raymonde Gagnon, Midwife and Professor in the Bachelor’s degree program of midwifery at the Université du Québec à Trois-Rivières
— « Midwifery Practice: personalized care from the beginnings of the profession »
2.35-2.50 pm Marie-Eve Blackburn, Ph.D. in Applied Human Sciences (UofM), Researcher at ÉCOBES - research and transfer of Cégep de Jonquière
— « Social representations of pharmacogenomics in Quebec: prospective elements»
2.50-3.05 pm Audrey Quintane, Ph.D. in Applied Human Sciences (UofM) and Doctor in Sociology of Université de Perpignan Via Domitia
— « Place de la médecine personnalisée dans la pratique en cardiologie »
3.05-3.20 pm Coffee-break and snacks + posters visit
3.20-3.50 pm Pre-closing Conference
Catherine Garnier, Professor (UQAM), Founder and International President of the International and Interdisciplinary Association on the Pharmaceutical Lifecycle (IIAPC)
—« Médecine personnalisée et chaîne des médicaments: même défi interdisciplinaire »
(in French with Simultaneous Translation)
3.50-5.20 pm Final Summit and reports from each theme's rapporteurs
Symposium on the Human Sciences and Interdisciplinarity Theme
Animated by Michel Rochon (Radio-Canada) and Daniel Weinstock (McGill), Director of IPPS, Professor of Law, Philosopher and Essayist
Roundtable Themes: •Scientific and social of the announced revolution implications; •Impacts of personalized care in Human and Social Sciences; •Enthusiasms of some and fears of others : what concertation ?; •Feature of an inform public action
Pavel Hamet, Canada Research Chair in Predictive Genomics of Hypertension and Cardiovascular Disease, Chief of Gene Medicine at CHUM, Doctor and Professor of Medicine (UofM)
Jean-Louis Denis, Canada Research Chair in Governance and Transformation of Health Organizations and Systems, Former President of the Institute of Health Services and Policy Research's (IHSPR) Advisory Board, Professor of Organizational Theory and Public Management (ÉNAP)
Richard Mayrand, Pharmacist, Recipient of the Louis-Hébert prize awarded by the OPQ, Jean Coutu’s Executive Vice President - Pharmacy and Government Affairs
Pierre Noreau, Interdisciplinary Researcher at the Centre de recherche en droit public, outgoing vice-president of the Agence universitaire de la Francophonie (AUF) and Professor of Law (UofM)
Awards, Graduate Students Contest
Closing of the Conference and rendez-vous for 2017
This content has been updated on 6 April 2016 at 20 h 42 min.